Qualification in apheresis
(Source: Journal of Clinical Apheresis)
Source: Journal of Clinical Apheresis - October 8, 2016 Category: Hematology Authors: Bruce S. Sachais Tags: Editorial Source Type: research
Human immunodeficiency virus associated thrombotic thrombocytopenic purpura, a clinical conundrum
This article illustrates that in patients with HIV‐TTP who do not respond to plasma infusion, early escalation to plasma exchange may help avoid life‐threatening complications such as seizures and even death. (Source: Journal of Clinical Apheresis)
Source: Journal of Clinical Apheresis - October 5, 2016 Category: Hematology Authors: Nathaniel C. Warner, Leroy B. Vaughan, Richard P. Wenzel Tags: Case Report Source Type: research
Plerixafor, cyclophosphamide and G ‐CSF and Blood cell mobilization in a patient with acute promyelocytic leukemia
(Source: Journal of Clinical Apheresis)
Source: Journal of Clinical Apheresis - September 30, 2016 Category: Hematology Authors: G. Jaimovich, M. Castro, B. Rosales Ostriz, M. Fernandez, D. Silveyra, R. Campestri Tags: Letter to the Editor Source Type: research
Red blood CELL exchange: 2015 American Society for Apheresis consensus conference on the management of patients with sickle cell disease
Abstract
The American Society for Apheresis (ASFA) conducted a one‐day consensus conference on red blood cell exchange (RBCx) in sickle cell disease (SCD) during its annual meeting in San Antonio, TX, on May 5, 2015. The authors of this article, a subcommittee of ASFA's Clinical Applications Committee, developed several questions with regard to pathophysiology of SCD and use of RBCx in the management of various complications. These questions were provided to the seven invited speakers who are the experts in the field of SCD. Two experts in the field moderated the proceedings of the conference, which was attended by more ...
Source: Journal of Clinical Apheresis - September 30, 2016 Category: Hematology Authors: Ravi Sarode, Samir K. Ballas, Alicia Garcia, Haewon C Kim, Karen King, Bruce Sachais, Lance A. Williams Tags: Commentary Source Type: research
Selective plasma exchange can reduce auto ‐antibodies in patients with bullous pemphigoid without affecting factor XIII and fibrinogen
Abstract
Bullous pemphigoid (BP) is an autoimmune blistering skin disorder characterized by circulating serum IgG antibodies against two hemidesmosomal proteins: BP180 and BP230. Fundamentally, immunosuppressive therapies are administered to treat this disease, but plasmapheresis can be added for refractory patients. We experienced the case of a 63‐year‐old patient with refractory BP for which we administered double filtration plasmapheresis (DFPP). His skin lesions improved along with decreased IgG BP180 antibodies, but factor XIII (FXIII) and fibrinogen were also reduced by DFPP repetition. Reportedly, deficiency of ...
Source: Journal of Clinical Apheresis - September 30, 2016 Category: Hematology Authors: Kahori Nasu, Norio Hanafusa, Masaomi Nangaku Tags: Brief Report Source Type: research
